Products

What will AGI do for Arsthinol?

This classification denotes an antiprotozoal agent with the molecular formula C11H14AsNO3S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QNT09A162Y, chemically known as 2-hydroxy-5-(4-hydroxymethyl-1,3,2-dithiarsolan-2-yl)acetanilid but generally known as arsthinol, which bears US NIH Compound Identifier 8414. European Medicines Agency schedules Arsthinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05572MIG. The term ARSTHINOL is an International Non-Proprietary Name. World Health Organization schedules arsthinol in its Anatomical Therapeutic Chemical (ATC) Classification. ARSTHINOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule arsthinol under HS 29349990 and SITC 51579. As of Q4 2014, ARSTHINOL remains the US FDA Preferred Term for this commodity. Arsthinol bears US NLM identifiers UMLS ID C0301341 and NCI Concept Code C76411. SMILES: CC(=O)NC1=C(C=CC(=C1)[AS]2SCC(S2)CO)O.

How AGI delivers it

Four ways AGI delivers for Arsthinol

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Arsthinol, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Arsthinol, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Arsthinol connects

measured by

  • Assay Puritymodel
  • Loss On Dryingmodel
  • Residual Solventmodel
  • Total Arsenic Contentmodel